First gene therapy approval for bladder cancer ... is what happened

1 Views
administrator
administrator
07/08/23

On 16th December 2022, US-FDA approved Adstiladrin first gene therapy for the treatment of high-risk Non-Muscle-Invasive Bladder Cancer. Subscribe channel for recent updates. #fdaapproved #cancer #bladdercancer #oncology #oncologyurology #doodle #doodleart #medicalupdate #educationupdate #cancerupdate #doodlevideo #genetherapy #fdaapproval #fda #lifesaving #cellandgenetherapy

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next